Tiago Girao, Chief Financial Officer at Immunovant, Inc. (IMVT), sold 6,798 shares at $38.69 ($263K) on 2026-07-23, disclosed to the SEC on 2026-07-24.
Open-market sale of $263k IMVT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| CYTX | BUY | 2015-08-19 | $10K | — | Filing → |
| CYTX | BUY | 2014-11-12 | $23K | — | Filing → |